EUS-guided ablation of pancreatic neoplasms

EUS-guided ablation of pancreatic neoplasms

Ablative therapies for locoregional therapy of pancreatic neoplastic lesions developed during the last decade to be utilized throughout surgical procedure at the moment are turning into additionally obtainable to be utilized underneath endoscopic ultrasound (EUS) steerage. The benefit of this strategy is obvious due to the shut proximity of the EUS transducer to the goal lesion, coupled with developments of particularly designed ablation gadgets, making the process minimally invasive, and probably sparing sufferers from the morbidity of this methodology when carried out surgically.

EUS-guided ablative methods which were utilized to pancreatic neoplastic cysts, pancreatic useful and non-functional neuroendocrine neoplasms and pancreatic ductal adenocarcinoma embody ethanol injection, radiofrequency ablation (RFA), a mix of bipolar RFA and cryoablation, laser remedy (LT) and photodynamic remedy (PDT). To this point, most of those procedures have been utilized to sufferers at excessive surgical threat or who refused surgical procedure. Nevertheless, extra research evaluating a few of these therapies additionally in chosen sufferers not at surgical threat have gotten obtainable.

These research will pave the street to use this therapeutic strategy to a extra in depth variety of sufferers, alone or in affiliation with different therapies, corresponding to immunomodulating medication. The current manuscript will critically assessment the obtainable proof within the subject of EUS-guided native ablative therapy of strong and cystic pancreatic neoplasms. Exosomes (EXOs) are small vesicles (30-200 nm) of endocytic origin, that are launched by many various cell sorts into the extracellular house. They might play a key position in facilitating cell-cell communication, underneath each physiological and pathological situations.

EXOs include a variety of RNA molecules and proteins. Their particular molecular signatures make them promising candidates in early analysis and prognosis of pancreatic ailments. EXOs might additionally present a brand new methodology to observe therapy response in sufferers affected by pancreatic most cancers and different ailments of the pancreas. Moreover they might assist to enhance present therapies through customized drugs approaches utilizing them as therapeutic automobiles themselves.

The exploration of quantitative intra-tumoral metabolic heterogeneity in dual-time 18 F-FDG PET/CT of pancreatic most cancers

 In complete, 183 PC sufferers have been analyzed retrospectively on this analysis. The standard metabolic parameters have been all statistically totally different between the early and delayed scans apart from metabolic tumor quantity (MTV). Within the radiomics, there have been 59 textural options. Nineteen of 59 texture options have been statistically totally different between the early and delayed scans. Options that have been greater than 10% totally different throughout two scans have been noticed in a considerable proportion of sufferers. Weak correlations have been solely discovered between MTV, TLG (Complete lesion glycolysis), SUVpeak and the RI of some texture options in early or delayed scans.

There have been clearly fewer options with important distinction in resectable PC group than in unresectable PC group. Most options displaying the distinction in unresectable group whereas no important distinction in resectable group. Options have been extracted based mostly on spatial distribution of 18F-FDG uptake in picture. Firstly, the feel options and the traditional metabolic parameters of the delayed scan have been each in contrast with that of the early scan. Statistically totally different knowledge was outlined amongst them. Secondly, the research evaluated the correlations between retention index (RI) of the feel options and the traditional metabolic parameters.

Lastly, the variation of texture options in dual-time PET/CT of resectable PC sufferers and unresectable PC sufferers was calculated individually. The mRNA expression profiles and corresponding clinicopathological data of PAC sufferers have been downloaded from The Most cancers Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, respectively. To additional discover the impact of hypoxia on the prognosis of sufferers with PAC in addition to the tumor immune microenvironment, we established a hypoxia threat mannequin and divided it into high- and low-risk teams according to the hypoxia threat rating.

EUS-guided ablation of pancreatic neoplasms

Lengthy non-coding RNA PART1 predicts a poor prognosis and promotes the malignant development of pancreatic most cancers by sponging miR-122

 qRT-PCR was utilized to detect PART1 expression in 45 instances of pancreatic most cancers sufferers. The chi-square check was carried out to evaluate the affiliation between PART1 expression and clinicopathologic options, and Kaplan-Meier methodology was utilized to guage total survival. In vitro CCK-8, transwell invasion, and circulation cytometry assays have been utilized to detect the results of PART1 on cell proliferation, invasion, and apoptosis, respectively. Luciferase reporter and RNA immunoprecipitation assays have been used to determine the regulatory mechanism between PART1 and miR-122. PART1 expression was upregulated in pancreatic most cancers tissues and cell traces.

Excessive PART1 expression was carefully correlated with tumor dimension, T classification, medical stage, and vascular invasion, and predicted a poor total survival. PART1 knockdown considerably suppressed cell proliferation and invasion skills of pancreatic most cancers however promoted cell apoptosis. PART1 was discovered to function a molecular sponge of miR-122, and miR-122 inhibition partially reversed the inhibitory phenotypes of PART1 knockdown on pancreatic most cancers cells. The Editor requested the authors for an evidence to account for the looks of strikingly comparable knowledge of their paper independently, though the authors by no means responded inside an affordable time to substantiate that the paper must be retracted.

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx302290-100g 100 µg
EUR 362.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx302290-20g 20 µg
EUR 162.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx302290-50g 50 µg
EUR 250

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx238257-100g 100 µg
EUR 350

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx145140-1096tests 10 × 96 tests Ask for price

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx145140-596tests 5 × 96 tests Ask for price

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx145140-96tests 96 tests
EUR 337.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx323587-100g 100 µg
EUR 250

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx323587-50g 50 µg
EUR 187.5

Cancer/testis Antigen 2 (CTAG2) Antibody

20-abx149592
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

Cancer/testis Antigen 2 (CTAG2) Antibody

abx027593-400ul 400 ul
EUR 627.6

Cancer/testis Antigen 2 (CTAG2) Antibody

abx027593-80l 80 µl
EUR 343.2

Cancer/testis Antigen 2 (CTAG2) Antibody

abx027593-400l 400 µl
EUR 518.75

Cancer/testis Antigen 2 (CTAG2) Antibody

abx376324-96tests 96 tests
EUR 225

Cancer/testis Antigen 2 (CTAG2) Antibody

abx344921-100l 100 µl
EUR 250

Cancer/testis Antigen 2 (CTAG2) Antibody

abx344921-50l 50 µl
EUR 187.5

Cancer/testis Antigen 2 (CTAG2) Antibody

abx375499-96tests 96 tests
EUR 337.5

Cancer/Testis Antigen 1A (CTAG1A) Antibody

20-abx111352
  • Ask for price
  • Ask for price
  • 150 ul
  • 50 ul

Cancer/Testis Antigen 1A (CTAG1A) Antibody

20-abx126874
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx128209
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx135754
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx027441-400ul 400 ul
EUR 627.6

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx027441-80l 80 µl
EUR 343.2

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx171540
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx331930-100ul 100 ul
EUR 510

Cancer/Testis Antigen 1B (CTAG1B) Antibody

abx128209-100l 100 µl
EUR 275

Cancer/Testis Antigen 1B (CTAG1B) Antibody

abx128209-1ml 1 ml
EUR 750

Cancer/Testis Antigen 1B (CTAG1B) Antibody

abx128209-200l 200 µl
EUR 337.5

Cancer/Testis Antigen 1B (CTAG1B) Antibody

abx171540-1ml 1 ml
EUR 787.5

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx111352-100l 100 µl
EUR 612.5

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx027441-400l 400 µl
EUR 518.75

Cancer/Testis Antigen 1B (CTAG1B) Antibody

abx135754-100tests 100 tests
EUR 175

Cancer/Testis Antigen 1 (CTAG1B) Antibody

abx433062-100g 100 µg
EUR 387.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)

20-abx316206
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)

abx316206-100g 100 µg
EUR 362.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)

abx316206-20g 20 µg
EUR 162.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP)

abx316206-50g 50 µg
EUR 250

Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)

20-abx316207
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)

abx316207-100g 100 µg
EUR 362.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)

abx316207-20g 20 µg
EUR 162.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC)

abx316207-50g 50 µg
EUR 250

Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)

20-abx316208
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)

abx316208-100g 100 µg
EUR 362.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)

abx316208-20g 20 µg
EUR 162.5

Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin)

abx316208-50g 50 µg
EUR 250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1)

MBS6002009-02mL 0.2(mL
EUR 695

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1)

MBS6002009-5x02mL 5x0.2mL
EUR 2975

ARMC3 (Cancer/testis antigen 81) Polyclonal Antibody

MBS9238385-01mL 0.1mL
EUR 415

ARMC3 (Cancer/testis antigen 81) Polyclonal Antibody

MBS9238385-5x01mL 5x0.1mL
EUR 1841

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody

CAU21749-100ul 100ul
EUR 235.2

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody

CAU21749-200ul 200ul
EUR 294

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (AP)

MBS6289627-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (AP)

MBS6289627-5x02mL 5x0.2mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (APC)

MBS6289628-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (APC)

MBS6289628-5x02mL 5x0.2mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (FITC)

MBS6289630-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (FITC)

MBS6289630-5x02mL 5x0.2mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (PE)

MBS6289637-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (PE)

MBS6289637-5x02mL 5x0.2mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Biotin)

MBS6289629-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Biotin)

MBS6289629-5x02mL 5x0.2mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 405)

MBS6289632-01mL 0.1mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 405)

MBS6289632-5x01mL 5x0.1mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 490)

MBS6289633-01mL 0.1mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 490)

MBS6289633-5x01mL 5x0.1mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 550)

MBS6289634-01mL 0.1mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 550)

MBS6289634-5x01mL 5x0.1mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 650)

MBS6289635-01mL 0.1mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 650)

MBS6289635-5x01mL 5x0.1mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 750)

MBS6289636-01mL 0.1mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (MaxLight 750)

MBS6289636-5x01mL 5x0.1mL
EUR 4250

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Azide free) (HRP)

MBS6289631-02mL 0.2mL
EUR 980

CTAG2, ID (CTAG2, ESO2, LAGE1, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1) (Azide free) (HRP)

MBS6289631-5x02mL 5x0.2mL
EUR 4250

Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)

MBS2026997-01mL 0.1mL
EUR 175

Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)

MBS2026997-02mL 0.2mL
EUR 220

Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)

MBS2026997-05mL 0.5mL
EUR 355

Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)

MBS2026997-1mL 1mL
EUR 435

Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B)

MBS2026997-5mL 5mL
EUR 1185

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2)

MBS645319-02mL 0.2mL
EUR 695

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2)

MBS645319-5x02mL 5x0.2mL
EUR 2975

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (AP)

MBS6289616-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (AP)

MBS6289616-5x02mL 5x0.2mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (APC)

MBS6289617-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (APC)

MBS6289617-5x02mL 5x0.2mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Biotin)

MBS6289618-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Biotin)

MBS6289618-5x02mL 5x0.2mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (FITC)

MBS6289619-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (FITC)

MBS6289619-5x02mL 5x0.2mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (PE)

MBS6289626-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (PE)

MBS6289626-5x02mL 5x0.2mL
EUR 4250

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human)

4-PAJ316Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B)

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803)

MBS6007563-01mg 0.1(mg
EUR 630

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803)

MBS6007563-5x01mg 5x0.1mg
EUR 2680

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) APC

MBS6136089-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) APC

MBS6136089-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (AP)

MBS6130786-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (AP)

MBS6130786-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (PE)

MBS6157301-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (PE)

MBS6157301-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (HRP)

MBS6151998-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (HRP)

MBS6151998-5x01mL 5x0.1mL
EUR 3800

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 405)

MBS6289621-01mL 0.1mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 405)

MBS6289621-5x01mL 5x0.1mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 490)

MBS6289622-01mL 0.1mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 490)

MBS6289622-5x01mL 5x0.1mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 550)

MBS6289623-01mL 0.1mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 550)

MBS6289623-5x01mL 5x0.1mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 650)

MBS6289624-01mL 0.1mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 650)

MBS6289624-5x01mL 5x0.1mL
EUR 4250

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 750)

MBS6289625-01mL 0.1mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (MaxLight 750)

MBS6289625-5x01mL 5x0.1mL
EUR 4250

Human Cancer/testis antigen 2 (CTAG2)

1-CSB-YP006127HUa4
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in Yeast

Human Cancer/testis antigen 2 (CTAG2)

1-CSB-EP006127HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in E.coli

Human Cancer/testis antigen 1 (CTAG1A)

1-CSB-YP006125HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in Yeast

Human Cancer/testis antigen 1 (CTAG1A)

1-CSB-EP006125HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in E.coli

Cancer/Testis Antigen 5.1 (SSX1) Protein

abx262587-10mg 10 mg
EUR 325

Cancer/Testis Antigen 5.1 (SSX1) Protein

abx262587-25mg 25 mg
EUR 6575

Cancer/Testis Antigen 5.1 (SSX1) Protein

abx262587-5mg 5 mg
EUR 225

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (Biotin)

MBS6141392-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (Biotin)

MBS6141392-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (FITC)

MBS6146695-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (FITC)

MBS6146695-5x01mL 5x0.1mL
EUR 3800

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Azide free) (HRP)

MBS6289620-02mL 0.2mL
EUR 980

CTAG1A, NT (CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A, Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 6.1, L antigen family member 2) (Azide free) (HRP)

MBS6289620-5x02mL 5x0.2mL
EUR 4250

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), PE

4-PAJ316Hu01-PE
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with PE.

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), APC

4-PAJ316Hu01-APC
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with APC.

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), Cy3

4-PAJ316Hu01-Cy3
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with Cy3.

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), HRP

4-PAJ316Hu01-HRP
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with HRP.

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 490)

MBS6200324-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 490)

MBS6200324-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 550)

MBS6210999-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 550)

MBS6210999-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 405)

MBS6189649-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 405)

MBS6189649-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 650)

MBS6221674-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 650)

MBS6221674-5x01mL 5x0.1mL
EUR 3800

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 750)

MBS6232349-01mL 0.1(mL
EUR 875

CTAG2 (ESO2, LAGE1, Cancer/Testis Antigen 2, CT2, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, Cancer/Testis Antigen 6.2, CT6.2, L Antigen Family Member 1, LAGE-1, MGC138724, MGC3803) (MaxLight 750)

MBS6232349-5x01mL 5x0.1mL
EUR 3800

Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), FITC

4-PAJ316Hu01-FITC
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with FITC.

Rabbit anti-human cancer/testis antigen 1A polyclonal Antibody

MBS710901-01mL 0.1mL
EUR 485

Rabbit anti-human cancer/testis antigen 1A polyclonal Antibody

MBS710901-5x01mL 5x0.1mL
EUR 2175

Recombinant Human Cancer/testis antigen 2

MBS1166239-002mgEColi 0.02mg(E-Coli)
EUR 255

The Editor has subsequently made the manager determination to retract this paper. The Editor apologizes to the readership for any inconvenience prompted. Thirty sufferers who underwent TP have been eligible for the research. Bowel motion frequency elevated over time, and the RBW and TSFT have been lowest by 1 12 months. The worldwide well being standing rating confirmed no important distinction over time.

Leave a Reply

Your email address will not be published. Required fields are marked *